Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare

Sakar Healthcare

23/09/2025 02:01

** Shares of Algorae Pharmaceuticals 1AI.AX rise 25% to A$0.010, their highest level since August 25

** The AI-enabled pharmaceutical co says it has entered an exclusive commercial licensing agreement with Sakar Healthcare SAKA.NS

** Agreement to launch five generic oncology medicines into the Australian and New Zealand markets

** Stock posts its biggest intraday pct gain since August 22

** Over 7 million shares change hands, compared with the 30-day average volume of about 1 million

** Stock up 33.3% YTD, including session's moves

 (Reporting by Adwitiya Srivastava in Bengaluru)

 ((Adwitiya.Srivastava@thomsonreuters.com))